Dexamethasone Sodium Phosphate Injection shortage
Current 19 presentations · 5 manufacturers · first FDA posting Feb 8, 2019 · last update Oct 15, 2026
Manufacturers: Eugia US LLC, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc., Mylan Institutional, a Viatris Company, Somerset Therapeutics, LLC
Stated reasons (per FDA): Demand increase for the drug
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 55150-304-25) | Eugia US LLC | Current Available |
— | Check wholesalers for inventory | Posted Feb 8, 2019 Updated Oct 2, 2026 |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01) | Fresenius Kabi USA, LLC | Current Unavailable |
Demand increase for the drug | Next release October 2026. Check wholesalers for inventory. | Posted Feb 8, 2019 Updated Oct 15, 2026 |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted Feb 8, 2019 Updated Oct 15, 2026 |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-30) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted Feb 8, 2019 Updated Oct 15, 2026 |
| Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted Feb 8, 2019 Updated Oct 15, 2026 |
| Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 63323-516-10) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted Feb 8, 2019 Updated Oct 15, 2026 |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-0210-10) | Fresenius Kabi USA, LLC | Current Available |
— | Checkwholesalers for inventory | Posted Feb 8, 2019 Updated Oct 15, 2026 |
| Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-0212-10) | Fresenius Kabi USA, LLC | Current Unavailable |
Demand increase for the drug | Next release January 2027. Check wholesalers for inventory. | Posted Feb 8, 2019 Updated Oct 15, 2026 |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-210-10) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted Feb 8, 2019 Updated Oct 15, 2026 |
| Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-212-10) | Fresenius Kabi USA, LLC | Current Unavailable |
Demand increase for the drug | Next release January 2027. Check wholesalers for inventory. | Posted Feb 8, 2019 Updated Oct 15, 2026 |
| Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Product will be made available as it is released. | Posted Feb 8, 2019 Updated Oct 14, 2026 |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Demand increase for the drug | Product temporarily on backorder. Additional lots will be available in the November 2026 timeframe. | Posted Feb 8, 2019 Updated Oct 14, 2026 |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional product will be made available as it is released. | Posted Feb 8, 2019 Updated Oct 14, 2026 |
| Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 67457-420-10) | Mylan Institutional, a Viatris Company | Current Available |
— | Posted Feb 8, 2019 Updated Oct 5, 2026 | |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30) | Mylan Institutional, a Viatris Company | Current Available |
— | Posted Feb 8, 2019 Updated Oct 5, 2026 | |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54) | Mylan Institutional, a Viatris Company | Current Available |
— | Posted Feb 8, 2019 Updated Oct 5, 2026 | |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-423-12) | Mylan Institutional, a Viatris Company | Current Available |
— | Posted Feb 8, 2019 Updated Oct 5, 2026 | |
| Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25) | Somerset Therapeutics, LLC | Current Available |
— | Posted Feb 8, 2019 Updated Sep 11, 2026 | |
| Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 70069-025-10) | Somerset Therapeutics, LLC | Current Available |
— | Posted Feb 8, 2019 Updated Sep 11, 2026 |